Format

Send to

Choose Destination
Med Princ Pract. 2019 Sep 27. doi: 10.1159/000503705. [Epub ahead of print]

Experiences of Adults using Continuous Subcutaneous Insulin Infusion: A Qualitative Study.

Abstract

OBJECTIVES:

. We aimed to determine the quality of life (QoL) of Kuwaiti adults in with type 1 diabetes mellitus (T1DM) who used continuous subcutaneous insulin infusions (CSIIs) and to understand their perception of this treatment.

BACKGROUND:

CSII is an effective and safe alternative to multiple daily injections for T1DM, with the potential to improve both glycemic control and QoL. Although CSII has been widely used in Kuwait, its effectiveness and benefits have not been properly evaluated. Healthcare providers and patients need more information on CSII before its initiation.

METHODS:

In this qualitative case study, semi-structured individual interviews were performed using a topic guide. Interviews were stopped at data saturation point. Subsequently, a thematic analysis of transcripts was performed.

RESULTS:

Eighteen adults with T1DM (8 males and 10 females; age, 31.4 ± 6.4 years; diabetes duration, 17.7 ± 9.5 years; CSII duration, 3.6 ± 2.4 years) were recruited from CSII clinic. Six main themes were studied: health benefits, lifestyle flexibility, improvement of mood and emotion, practical problems, physical and personal effects, and self-confidence to manage diabetes. CSII positively affected the QoL of participants', most notably by enhancing lifestyle flexibility; however, important negative qualities were also reported.

CONCLUSION:

The identified themes highlight the complexity of the experiences of participants, and can be used to provide a framework to help healthcare providers understand how people with T1DM become aware of their treatment regimens. It is important to identify the positive aspects of CSII and not focus only on its negative effects. .

PMID:
31557759
DOI:
10.1159/000503705
Free full text

Supplemental Content

Full text links

Icon for S. Karger AG, Basel, Switzerland
Loading ...
Support Center